Answer
The licence covers susceptible pregnant people, particular newborn and premature babies, and susceptible immunocompromised adults or children. Current UK guidance determines which alternative is used.
Sources for this answer
- Human Varicella-Zoster Immunoglobulin — Current selected SmPCemc · Summary of Product Characteristics
- UK Government